Abstract
THE use of halogenated pregnene derivatives, especially of 9α-fluoro-hydrocortisone, has been undoubtedly the greatest recent advance in the experimental pharmacology of steroids, as evidenced by the outstanding work of Fried and his colleagues1 on the various potencies of this corticoid. In the present communication we discuss results obtained in guinea pigs, in which we tried to prevent the abdominal fibromatogenic action of œstrogen; other antiœstrogenic potencies also have been studied.
This is a preview of subscription content, access via your institution
Access options
Similar content being viewed by others
References
Fried, J., Ann. N.Y. Acad. Sci., 61, 573 (1955).
Mardones, E., Iglesias, R., and Lipschutz, A., Nature, 174, 839 (1954).
Mardones, E., Jadrijevic, D., and Lipschutz, A., Nature, 177, 478 (1956).
Mardones, E., Iglesias, R., and Lipschutz, A., Experientia, 9, 303 (1953).
Huggins, C., and Jensen, E. V., J. Exp. Med., 102, 347 (1955).
Velardo, J. J., and Sturgis, S. H., J. Cl. Endocrinol. Met., 16, 496 (1956).
Fuenzalida, F., and Lipschutz, A., J. Cl. Endocrinol. Met., 13, 1201 (1953).
Scott's “Standard Methods of Chemical Analysis”, 5th edit., 1, 423 (1952).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LIPSCHUTZ, A., JADRIJEVIC, D., GIRARDI, S. et al. Antifibromatogenic Potency of 9α-fluoro Derivatives of Progesterone. Nature 178, 1396–1397 (1956). https://doi.org/10.1038/1781396a0
Issue Date:
DOI: https://doi.org/10.1038/1781396a0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
